Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.47B | 10.29B | 10.40B | 10.58B | 10.58B |
| Total Other Revenue | 32.46M | 29.63M | 29.63M | 33.15M | 28.55M |
| Total Revenue | 10.50B | 10.32B | 10.43B | 10.61B | 10.61B |
| Cost of Revenue | 8.79B | 8.66B | 8.69B | 8.82B | 8.72B |
| Gross Profit | 1.71B | 1.66B | 1.73B | 1.80B | 1.89B |
| SG&A Expenses | 1.11B | 1.07B | 1.12B | 1.11B | 1.16B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 37.19M | 17.33M | 9.13M | -18.77M | -14.21M |
| Total Operating Expenses | 10.03B | 9.85B | 9.93B | 10.02B | 9.98B |
| Operating Income | 467.41M | 471.20M | 498.69M | 593.35M | 628.66M |
| Income Before Tax | 478.67M | 467.12M | 501.98M | 606.97M | 666.89M |
| Income Tax Expenses | 77.27M | 77.22M | 84.45M | 103.51M | 111.20M |
| Earnings from Continuing Operations | 401.40 | 389.90 | 417.53 | 503.46 | 555.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.75M | -17.67M | -22.96M | -27.29M | -29.34M |
| Net Income | 386.65M | 372.23M | 394.58M | 476.17M | 526.35M |
| EBIT | 467.41M | 471.20M | 498.69M | 593.35M | 628.66M |
| EBITDA | 551.24M | 556.28M | 586.52M | 683.55M | 715.28M |
| EPS Basic | 0.24 | 0.23 | 0.24 | 0.29 | 0.32 |
| Normalized Basic EPS | 0.18 | 0.18 | 0.19 | 0.22 | 0.24 |
| EPS Diluted | 0.24 | 0.23 | 0.24 | 0.29 | 0.32 |
| Normalized Diluted EPS | 0.18 | 0.18 | 0.19 | 0.22 | 0.24 |
| Average Basic Shares Outstanding | 6.50B | 6.50B | 6.50B | 6.50B | 6.50B |
| Average Diluted Shares Outstanding | 6.50B | 6.50B | 6.50B | 6.50B | 6.50B |
| Dividend Per Share | 0.11 | 0.11 | 0.11 | 0.16 | 0.16 |
| Payout Ratio | 63.57% | 84.05% | 79.08% | 46.37% | 41.93% |